跳至主要内容
临床试验/CTRI/2022/06/043487
CTRI/2022/06/043487尚未招募未知

Assessing prevalence and risk of lung morbidities including lung nodules and cancer using non-contrast CT among PLHIV in Pune, India - LMCS PLHIV

TREAT Asia amfAR The Foundation for AIDS Research through a grant from the US NIH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • a.Men, women, and transgender persons known to be PLHIV ââ?°Â¥18 years of age.
  • (Note: Participants must be able to show proof that they are living with HIV, either by having a unique treatment number associated with the BJGMC-SGH ART center or a government provided HIV treatment book. A separate HIV test will not be performed in the study)
  • b.Willingness to undergo at least one chest NCCT.
  • c.Ability of the participant to provide informed consent.
  • (Note: Illiterate participants will be enrolled based on local regulatory policies, with appropriate provisions for informed consent)

排除标准

  • a.Unwillingness to undergo at least one chest NCCT.
  • b.Having undergone a computed tomography (CT) of any part of the body, positron emission tomography (PET) or interventional radiology procedure (coronary angiography, angioplasty, etc.) within one year prior to the anticipated enrollment date.
  • c.Men, women or transgender PLHIV with cognitive, hearing or language impairment.
  • d.Men, women or transgender persons with unknown HIV status.
  • e.Men, women or transgender PLHIV with a history of lung cancer or having received treatment for lung cancer in the past.
  • f.Pregnant women.
  • g.Inability/ Unwillingness to provide informed consent.

研究者

发起方
TREAT Asia amfAR The Foundation for AIDS Research through a grant from the US NIH

相似试验